BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20431978)

  • 1. Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study.
    Tsai S; Choti MA; Assumpcao L; Cameron JL; Gleisner AL; Herman JM; Eckhauser F; Edil BH; Schulick RD; Wolfgang CL; Pawlik TM
    J Gastrointest Surg; 2010 Jul; 14(7):1143-50. PubMed ID: 20431978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma?
    Khan S; Sclabas G; Reid-Lombardo K; Sarr MG; Nagorney D; Kendrick ML; Que FG; Donohue JH; Huebner M; Lohse C; Farnell MB
    J Gastrointest Surg; 2010 Nov; 14(11):1820-5. PubMed ID: 20676790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy.
    Williams TK; Rosato EL; Kennedy EP; Chojnacki KA; Andrel J; Hyslop T; Doria C; Sauter PK; Bloom J; Yeo CJ; Berger AC
    J Am Coll Surg; 2009 Feb; 208(2):210-7. PubMed ID: 19228532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing body mass index portends abbreviated survival following pancreatoduodenectomy for pancreatic adenocarcinoma.
    Mathur A; Luberice K; Paul H; Franka C; Rosemurgy A
    Am J Surg; 2015 Jun; 209(6):969-73. PubMed ID: 25916614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Gaujoux S; Torres J; Olson S; Winston C; Gonen M; Brennan MF; Klimstra DS; D'Angelica M; DeMatteo R; Fong Y; House M; Jarnagin W; Kurtz RC; Allen PJ
    Ann Surg Oncol; 2012 Sep; 19(9):2908-16. PubMed ID: 22411205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
    Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
    Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer.
    Dandona M; Linehan D; Hawkins W; Strasberg S; Gao F; Wang-Gillam A
    Pancreas; 2011 Aug; 40(6):931-7. PubMed ID: 21747317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher body mass index deteriorates postoperative outcomes of pancreaticoduodenectomy.
    Zou SY; Wang WS; Zhan Q; Deng XX; Shen BY
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):163-168. PubMed ID: 31862346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.
    Yeo CJ; Cameron JL; Sohn TA; Coleman J; Sauter PK; Hruban RH; Pitt HA; Lillemoe KD
    Ann Surg; 1999 May; 229(5):613-22; discussion 622-4. PubMed ID: 10235519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher body mass index is associated with reinterventions and lower maturation rates after upper extremity arteriovenous access creation.
    Raulli SJ; Sather K; Dicken QG; Farber A; Kalish JA; Eslami MH; Zhang Y; Cheng TW; Levin SR; Siracuse JJ
    J Vasc Surg; 2021 Mar; 73(3):1007-1015. PubMed ID: 32442609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
    Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
    JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer.
    Pausch T; Hartwig W; Hinz U; Swolana T; Bundy BD; Hackert T; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S81-8. PubMed ID: 22770957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Body Mass Index on Survival of Pancreatic Cancer Patients in Japan.
    Okura T; Fujii M; Shiode J; Ito Y; Kojima T; Nasu J; Niguma T; Yoshioka M; Mimura T; Yamamoto K
    Acta Med Okayama; 2018 Apr; 72(2):129-135. PubMed ID: 29674761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of obesity on surgical outcome after pancreaticoduodenectomy.
    Noun R; Riachy E; Ghorra C; Yazbeck T; Tohme C; Abboud B; Naderi S; Chalhoub V; Ayoub E; Yazbeck P
    JOP; 2008 Jul; 9(4):468-76. PubMed ID: 18648138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
    Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
    Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
    Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
    Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.